Why This Analyst Sees 2 Enterprise Software Players Doing Much Better in 2017
Sentiment in the space has been turning more negative, but one key analyst sees software growth stocks as better poised for growth in 2017 than their counterparts.
All Work
Chris Lange
What Could Help Exxon and Chevron Repeat 2016 Gains in 2017
2016 was a total reversal of fortune for the big oil companies. Rather impressive gains seen in shares of Chevron and in Exxon Mobil.
Tuesday’s Monster Moves You May Have Missed
Markets have been holding near their highs as we begin the New Year, and this has largely been propped up by the Dow Jones Industrial Average (DJIA) and larger companies making gains to close…
4 Major Earnings That Could Prop Up the Trump Rally
The Trump rally, as many are calling it, helped push the markets to these highs but it still has to be seen if this rally is fundamentally sound.
Braeburn Pharmaceuticals Gears Up for IPO
Braeburn Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Tuesday’s Biggest Biotech and Pharma Moves
To kick off the New Year, Clovis Oncology a few other biotech companies made massive runs on this first day of trading in 2017.
Jounce Therapeutics Files for IPO
Jounce Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Is This the Implosion of Inotek?
Inotek Pharmaceuticals saw its shares get more than halved early on Tuesday after the company provided an update on its late-stage glaucoma trial.
SEC Settles FCPA Charges With US Cable Company
The SEC has announced that Kentucky-based General Cable has agreed to pay over $75 million to resolve parallel SEC and U.S. Department of Justice investigations regarding its violations of the Foreign Corrupt Practices Act.
7 Key FDA Decisions and Catalysts Expected in January and February
24/7 Wall St. has collected several catalysts for biotech and pharmaceutical companies that are coming up in the first two months of 2017.
SEC Settles EB-5 Fraud Charges With Florida Businessman
The SEC has announced that a Florida-based businessman has agreed to settle charges that he misused investor funds that were intended to create U.S. jobs through the EB-5 Immigrant Investor Program.
EndoLogix Recovers Slightly After Resuming Shipments
Endologix shares dropped sharply on news of a temporary hold on the shipments of its abdominal aortic aneurysms products, but now that the company is resuming shipments, the stock has recovered somewhat.
Cempra Shares Get Halved After Receipt of CRL From the FDA
Shares of Cempra were halved on Thursday after the company received a Complete Response Letter from the U.S. Food and Drug Administration (FDA).
New Funding Lets Sears Fight Another Day
Sears has secured a standby letter of credit facility, which will provide the company with additional liquidity to fund its operations. In other words, Sears will live to fight another day.
Ardagh Gears Up for IPO
Ardagh Finance Holdings has amended its filing with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
AppDynamics Files for IPO
AppDynamics has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Galena Rises on FDA Approval
Galena Biopharma, Inc. (NASDAQ: GALE) saw its shares jump on Wednesday after a key U.S. Food and Drug Administration (FDA) approval. The company announced that it has confirmed the regulatory pathway to advance GALE-401…
SEC Charges California Lawyer With Stealing Investor Funds
The U.S. Securities and Exchange Commission (SEC) recently charged a California-based attorney with defrauding investors seeking to participate in the EB-5 immigrant investor program, stealing their funds to buy a yacht and prop up…
Presidio Gears Up for IPO
Presidio has amended its filing with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
SEC Issues Charges Against Chinese Traders After Law Firm Hack
The SEC has charged three Chinese traders with fraudulently trading on hacked, nonpublic, market-moving information stolen from two prominent New York-based law firms.